It's easy to get sucked into the "gee-whiz" aspect of a lot of new technology, and that probably explains why bubbles are much more common in tech and health care than in industrials or transports. It's easy to dream of how gene sequencing might change the world; quite a bit harder to imagine the same from a new hydraulic component. Unfortunately, the reality is that life sciences is not the eternal growth engine that investors have long hoped.
Although investors in life sciences stocks like Life Technologies (Nasdaq:LIFE) have seen a lot of pain as Wall Street reorients its expectations, the worst may be over. With more realistic expectations in place, it may be time to consider Life Tech as a good blue-chip play on a sector that may not be the stuff of dreams, but is hardly a nightmare. (For related reading, see A Primer On The Biotech Sector.)
To read more, please follow this link:
http://stocks.investopedia.com/stock-analysis/2011/Renewed-Realism-May-Make-Life-Tech-A-Buy-LIFE-PACB-ILMN-DHR-A-MTD-WAT-AFFX-BRKR-PKI1130.aspx
No comments:
Post a Comment